Why Pfizer Is My Largest Healthcare Position

Healthcare stocks have been out of vogue with investors since late 2022. Myriad reasons underlie the negative sentiment toward the healthcare sector, but in some instances, this dour take isn't entirely warranted. Pharmaceutical titan Pfizer (NYSE: PFE) is a case in point.The drugmaker's shares have lost 47% of their value from their three-year high and currently trade near a historically low forward price-to-earnings ratio (P/E) of just 8.7. Here's why Pfizer is my largest healthcare position, despite its poor showing over the past few years.Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool